Panoramic Health Launches Clinical Research Division to Drive Discovery of Novel Kidney Disease Therapies
26 oct. 2022 08h00 HE
|
Panoramic Health
TEMPE, Ariz., Oct. 26, 2022 (GLOBE NEWSWIRE) -- Today, Panoramic Health℠, the nation's leading integrated value-based kidney care platform, announced the launch of its clinical research division...
Chronic Kidney Disease [CKD] Nutritional Supplement Market to Exceed Value of US$ 5.0 Bn by 2031, Notes TMR Report
31 août 2022 10h30 HE
|
Transparency Market Research
Wilmington, Delaware, United States, Aug. 31, 2022 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global chronic kidney disease [CKD] nutritional supplement market size is...
Clarus Announces Initiation of Phase 4 Clinical Trial of JATENZO® (testosterone undecanoate) for the Treatment of Hypogonadal Men with Chronic Kidney Disease
16 mars 2022 09h05 HE
|
Clarus Therapeutics Holdings, Inc.
JATENZO is the first and only FDA-approved oral softgel for testosterone (T) replacement therapy in adult males who have deficient T due to certain medical conditions Clarus expects to announce...
Renibus Therapeutics Announces Appointment of Frank Stonebanks as CEO and $35 Million Series A Funding
15 févr. 2022 09h00 HE
|
Rénibus Therapeutics Inc.
Founder, CEO and healthcare venture capitalist, Stonebanks brings 25 years of experience to Renibus leadership team Renibus closes $35 million Series A; Funds will be used to advance the development...
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Reata Pharmaceuticals, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – RETA
09 févr. 2022 17h15 HE
|
The Rosen Law Firm PA
NEW YORK, Feb. 09, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Reata Pharmaceuticals, Inc. (NASDAQ: RETA) between...
Deepak Suri Named Chief Information Officer at Healthmap Solutions
21 déc. 2021 09h05 HE
|
Healthmap Solutions
TAMPA, Fla., Dec. 21, 2021 (GLOBE NEWSWIRE) -- Healthmap Solutions, Inc. (Healthmap), an NCQA accredited kidney population health management company, announced the appointment of Deepak Suri as its...
Global Renal Care Management Market Research Report 2021: Value-based Renal Care to Provide a Strong Platform for Payer-driven Innovations and Major Industry Disruptions
29 sept. 2021 07h13 HE
|
Research and Markets
Dublin, Sept. 29, 2021 (GLOBE NEWSWIRE) -- The "Global Renal Care Management Growth Opportunities" report has been added to ResearchAndMarkets.com's offering. The global prevalence of CKD is...
ARDX FINAL DEADLINE TUESDAY: ROSEN, TRUSTED NATIONAL TRIAL COUNSEL, Encourages Ardelyx, Inc. Investors with Losses to Secure Counsel Before Important September 28 Deadline in Securities Class Action – ARDX
26 sept. 2021 15h15 HE
|
The Rosen Law Firm PA
NEW YORK, Sept. 26, 2021 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Ardelyx, Inc. (NASDAQ: ARDX) between August 6, 2020 and...
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Ardelyx, Inc. Investors with Losses to Secure Counsel Before Important September 28 Deadline in Securities Class Action – ARDX
17 sept. 2021 19h15 HE
|
The Rosen Law Firm PA
NEW YORK, Sept. 17, 2021 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Ardelyx, Inc. (NASDAQ: ARDX) between August 6, 2020 and...
ARDX INVESTOR NOTICE: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Ardelyx, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – ARDX
19 août 2021 16h15 HE
|
The Rosen Law Firm PA
NEW YORK, Aug. 19, 2021 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Ardelyx, Inc. (NASDAQ: ARDX) between August 6, 2020 and...